There is described a method for the prophylactic or curative treatment of a disease condition of the gastrointestinal tract, which condition has an allergic basis, in cattle or pigs, which comprises administering an active ingredient having sodium cromoglycate like activity to an animal suffering, or liable to suffer, from such a condition. There are also described compositions and mixtures for use in the treatment of the animals.

There is described a method for the prophylactic or curative treatment of a disease condition having an allergic basis in cats, dogs or horses or a condition of the respiratory tract having an allergic basis in cattle which comprises administering an active ingredient having sodium cromoglycate like activity to an animal suffering, or liable to suffer, from such a condition. There are also described compositions and mixtures for use in the treatment of the animals.

A vaccine against Marek's disease is produced from a newly isolated Marek's disease virus which is unattenuated and naturally nononcogenic, even in immunosuppressed chickens.

A new concept of pregnancy and disease prevention is provided by a medicated tampon in the form of a soft, porous foam ball, which is easily insertable into the vagina to cover the cervical area and which is impregnated with a safe spectrum of antibiotics for control of venereal disease and with a contraceptive for control of pregnancy. The tampon may be inserted before intercourse to remain in place during intercourse.

A vaccine for Tyzzer's disease in rabbits is produced from inactivated hepatic or intestinal tissue of immunosuppressed rodents which have been infected with Bacillus piliformis.

A vaccine comprised of a purified capsid protein of foot-and-mouth disease virus emulsified in an adjuvant was found to protect swine against the disease. The immunizing protein is the protein of the virus coat that is sensitive in situ to cleavage with trypsin. It is also the protein that migrates as VP.sub.3 when isolated by the method of polyacrylamide gel separation used in this invention rather than migrating as VP.sub.1, or VP.sub.2 as it does when isolated by other methods.

There is described a medicament in pellet form characterized in that the pellet is soft, is from 10 to 1,000, preferably 30 to 500 microns, in diameter and comprises an agglomeration of individual medicament particles at least 90%, and preferably at least 95%, by weight of which have a diameter of less than 10 microns. Processes for making the soft pellets are also described.

What is disclosed is a method for the treatment of Parkinsonism or of psychic disturbances in a patient suffering therefrom, which method comprises orally or parenterally administering to said patient an effective amount of an active agent selected from the group consisting of (+)-trans-2-phenylcyclopropyl amine and physiologically acceptable acid addition salts thereof, said agent being essentially free of the corresponding (-)-enantiomer and its salts.

A disease diagnostic method and apparatus in which a two-dimensional pattern diagram representing the relation between integrated values of peaks and the retention times in a chromatogram of substances in a body fluid of a subject is obtained to be geographically compared, for disease diagnostic purpose, with a two-dimensional pattern diagram representing the relation between integrated values of peaks and the retention times in a chromatogram obtained through separating and detecting substances...

A new concept of pregnancy and disease prevention is provided by a medicated tampon in the form of a soft, porous foam ball of substantially spherical configuration, which is easily insertable into the vagina to cover the cervical area and which is impregnated with a contraceptive for control of pregnancy, and/or with a safe spectrum of antibiotics for control of venereal disease. The tampon may be inserted before intercourse to remain in place during intercourse.